title: Muscarinic receptor activation potentiates the effect of spinal cord stimulation on pain-related behavior in rats with mononeuropathy.
abstract: Spinal cord stimulation (SCS) has proven to be a valuable treatment in neuropathic pain. Our previous animal experiments performed on rat models of SCS and ensuing clinical trials have demonstrated that intrathecal (i.t.) administration of subeffective doses of certain drugs may enhance the pain relieving effect of SCS in cases with unsatisfactory SCS outcome. Recently, an augmented release of spinal acetylcholine acting on muscarinic receptors has been shown to be one of the mechanisms involved in SCS. The present study was performed to examine whether cold hypersensitivity and heat hyperalgesia in rats with partial sciatic nerve injuries can be attenuated by SCS in the same way as tactile hypersensitivity and to explore a possibly synergistic effect of SCS and a muscarinic receptor agonist, oxotremorine. Rats with signs of neuropathy were subjected to SCS applied in awake, freely moving condition. Oxotremorine was administered intrathecally. Tactile, cold and heat sensitivities were assessed by using von Frey filaments, cold spray and focused radiant heat, respectively. Oxotremorine i.t. dose-dependently suppressed the tactile hypersensitivity. SCS markedly increased withdrawal thresholds (WTs), withdrawal latencies and cold scores. When combining SCS with a subeffective dose of oxotremorine i.t., the suppressive effect of SCS on the pain-related symptoms was dramatically enhanced in rats failing to obtain a satisfactory effect with SCS alone. In conclusion, the combination of SCS and a drug with selective muscarinic receptor agonistic properties could be an optional therapy, when SCS per se has proven inefficient.
authors.affiliation: Department of Clinical Neuroscience, Section of Neurosurgery, Karolinska Institutet, Stockholm 171 76, Sweden. zhiyang.song@ki.se
authors.forename: Zhiyang
authors.initials: Z
authors.lastname: Song
authors.forename: Björn A
authors.initials: BA
authors.lastname: Meyerson
authors.forename: Bengt
authors.initials: B
authors.lastname: Linderoth
mesh_terms: D000818:Animals; D003080:Cold Temperature; D003131:Combined Modality Therapy; D004599:Electric Stimulation Therapy; D004567:Electrodes, Implanted; D006358:Hot Temperature; D006941:Hyperesthesia / Q000628:therapy; D007278:Injections, Spinal; D008297:Male; D020422:Mononeuropathies / Q000150:complications / Q000628:therapy*; D018721:Muscarinic Agonists / Q000008:administration & dosage*; D009437:Neuralgia / Q000209:etiology / Q000628:therapy*; D010095:Oxotremorine / Q000008:administration & dosage*; D017288:Pain Threshold / Q000187:drug effects; D051381:Rats; D017207:Rats, Sprague-Dawley; D011976:Receptors, Muscarinic / Q000187:drug effects / Q000378:metabolism; D012584:Sciatic Nerve / Q000293:injuries; D013116:Spinal Cord / Q000187:drug effects / Q000378:metabolism*
chemical_list: D018721:Muscarinic Agonists; D011976:Receptors, Muscarinic; D010095:Oxotremorine